The 12th China-Japan-Korea Symposium on Radiopharmaceutical Sciences

Award

Young Investigation Award

Dr. Hiroyuki Watanabe, Kyoto University, JAPAN
Title: Development of Bimodal Agents for Combined Use in Auger Electron and Photodynamic Cancer Therapy

Dr. Jiyoon Kim, Seoul National University College of Medicine, KOREA
Title: Development of a Folate-Albumin/ICG Complex for Enhanced Targeting and imaging of Endometrial Cancer Metastasis

Dr. Xi-Yang Cui, Peking University, CHINA
Title: Covalent Targeted Radioligands Potentiate Radionuclide Therapy


Oral Presentation Award

1st place
Dr. Xinlin Wang, Beijing Normal University, CHINA
Title: Design, Preclinical Evaluation, and First-in-Human PET Study of [68Ga]Ga-PSFA, a FAP/PSMA Heterobivalent Tracer

2nd place
Dr. Kazuma Nakashima, Kyoto University, JAPAN
Title: Development of positively-charged chelating agents that control the biodistribution of radioimmunoconjugates

3rd place
Mr. Hiroaki Echigo, Kanazawa University, JAPAN
Title: Development of an At-211 labeled RGD peptide with an albumin binding moiety and optimization of its pharmacokinetics

3rd place
Mr. Hiroki Jinda, Kyoto University, JAPAN
Title: Novel cathepsin B substrate-containing chelating agent to enhance intracellular retention of radioimmunoconjugates in tumor

3rd place
Dr. Atsuki Abe, The University of Tokyo, JAPAN
Title: Development of novel SPECT probes targeting aminopeptidase activity to detect peritoneal dissemination

6th place
Dr. Yizheng Wang, Chinese Academy of Sciences, CHINA
Title: Production of radiometals in medical cyclotron using liquid targets: case studies of 44gSc and 89gZr


Poster Presentation Award

1st place
Mr. Shohei Tsuchihashi, Kyoto University, JAPAN
Title: Application of albumin binder to pretargeting strategy for increasing tumor uptake

2nd place
Ms. Yuko Hirata, The University of Tokyo, JAPAN
Title: Development of Novel Highly Accumulating At-211 Drugs Targeting Aminopeptidase Activity

3rd place
Mr. Kazuma Sugahara, Chiba University, JAPAN
Title: Radiohalogen-labeled cancer theranostic compounds targeting fibroblast activation protein

3rd place
Mr. Kazuki Matsunaga, Kanazawa University, JAPAN
Title: Development of DNA-targeted probes using thermosensitive liposomes for Auger electron therapy

5th place
Ms. Fuko Hirano, Osaka Medical and Pharmaceutical University, JAPAN
Title: Development of 5-[18F]F-αMe-3BPA as a LAT1-targeted probe for PET imaging

6th place
Dr. Sébastien Guillet, The National Centre for Scientific Research, FRANCE
Title: Design and evaluation of 211At metal N-Heterocyclic Carbenes for targeted alpha therapy

6th place
Dr. Yuto Kondo, Fukushima Medical University, JAPAN
Title: One-Pot Two-Step Radioiodination Reaction Using Copper-Mediated Iododeboronation and Azide–Alkyne Cycloaddition

6th place
Dr. Kohei Nakajima, Hokkaido University, JAPAN
Title: Combination of anti-PD-1 and radiation therapies diminishes tumor hypoxia by enhancing anti-cancer immunity